- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:01 | Kelyniam Global Inc: Kelyniam Global Reports 2025 Financial Results | 33 | PR Newswire | Strong Second-Half Momentum Drives 85% Net Loss Improvement; FDA Clearance Secured for Innovative Fusion Biomaterial Implant; Board Rejects Undervalued Acquisition... ► Artikel lesen | |
| 13.11.25 | Kelyniam Global Inc.: Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP Fusion Biomaterial in Cranial Implants | 377 | GlobeNewswire (Europe) | CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from... ► Artikel lesen | |
| KELYNIAM GLOBAL Aktie jetzt für 0€ handeln | |||||
| 10.11.25 | Kelyniam Global Inc: Kelyniam Global Announces Q3 2025 Financial Results | 84 | PR Newswire | CANTON, Conn., Nov. 10, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today reported financial results... ► Artikel lesen | |
| 07.11.25 | Kelyniam Global Inc.: Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products | 64 | GlobeNewswire (Europe) | CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing... ► Artikel lesen | |
| 11.08.25 | Kelyniam Global Inc: Kelyniam Global Announces Q2 2025 Financial Results | 299 | PR Newswire | CANTON, Conn., Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced... ► Artikel lesen | |
| 12.05.25 | Kelyniam Global Inc: Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership | 60 | PR Newswire | CANTON, Conn., May 12, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 10,595 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| BRIGHTSPRING HEALTH SERVICES | 38,350 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 2,740 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,220 | -2,08 % | DZ BANK stuft Siemens Healthineers auf 'Positiv' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers von 55 auf 53 Euro gesenkt, die Einstufung aber auf "Kaufen" belassen. Temporärer Gegenwind verdecke die operative... ► Artikel lesen | |
| FRESENIUS | 46,645 | +0,08 % | Aktuelle Aktien-Empfehlungen: Ströer, Fresenius, Volkswagen & Co. | Mehrere europäische Aktien stehen aktuell im Fokus der Analystenhäuser. Eine Reihe neuer Studien bestätigt Kaufempfehlungen für Unternehmen aus unterschiedlichen Branchen - von Außenwerbung über Industrieanlagen... ► Artikel lesen | |
| PROGYNY | 17,510 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| ONCOLOGY INSTITUTE | 2,850 | 0,00 % | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | ||
| PROCEPT BIOROBOTICS | 27,140 | 0,00 % | PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy | UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq:... ► Artikel lesen | |
| BILLIONTOONE | 69,07 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,000 | -0,73 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,680 | -0,23 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| ESSILORLUXOTTICA | 202,00 | -1,85 % | EssilorLuxottica And Dolce&Gabbana Renew Global Eyewear Partnership Until 2050 | PARIS (dpa-AFX) - EssilorLuxottica and Dolce&Gabbana announced the extension of their current license agreement through 2050. Under this renewed partnership, EssilorLuxottica will continue to... ► Artikel lesen | |
| HEARTFLOW | 20,490 | -1,44 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,170 | +0,79 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery | KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced a strategic... ► Artikel lesen |
KELYNIAM GLOBAL INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KELYNIAM GLOBAL INC finden Sie auf Wallstreet Online.